Does the menopausal status of female gynecologists affect their prescription of menopausal hormone therapy?
Artículo
Open/ Download
Access note
Acceso a solo metadatos
Date
2016Metadata
Show full item record
Cómo citar
Vallejo, M. S.
Cómo citar
Does the menopausal status of female gynecologists affect their prescription of menopausal hormone therapy?
Author
- Vallejo, M. S.;
- Witis, S.;
- Ojeda, E.;
- Mostajo, D.;
- Morera, F.;
- Meruvia, N.;
- Martino, M.;
- Lima, S.;
- Espinoza, M. T.;
- Castillo, O.;
- Campostrini, B.;
- Danckers, L.;
- Blumel Méndez, Juan;
- Tserotas, K.;
- Sánchez, H.;
- Salinas, C.;
- Saavedra, J.;
- Rojas, J. A.;
- Onatra, W.;
- Monterrosa, A.;
- Montano, A.;
- Martínez, J.;
- González, E.;
- Gómez, G.;
- Calle, A.;
- Broutin, G.;
- Bencosme, A.;
- Arteaga, E.;
- Ayala, F.;
- Chedraui, P.;
Abstract
Objective: To evaluate whether menopausal status and symptoms among female gynecologists would influence their clinical behavior related to menopausal hormone therapy (MHT).Methods: Female gynecologists of 11 Latin American countries were requested to fill out the Menopause Rating Scale and a questionnaire containing personal information and that related to MHT use.Results: A total of 818 gynecologists accepted to participate (86.4%). Overall, the mean age was 45.010.7 years, 32.2% were postmenopausal, and 17.6% worked in an academic position; 81.8% reported that they would use MHT if they have symptoms, regardless of menopausal status. Academic gynecologists favor personal MHT use at a higher rate (p = 0.04) and have a higher MHT prescription rate as compared to non-academic ones (p = 0.0001). The same trend was observed among post- as compared to premenopausal ones (p = 0.01) and among those who had hysterectomy alone as compared to those experiencing natural menopause (p = 0.002). The presence of menopausal symptoms did not influence their MHT prescription. Current use of MHT and alternative therapy was higher among post- than premenopausal gynecologists (both, p=0.0001) and among those who had undergone hysterectomy than those experiencing natural menopause. A 38.5% perceived breast cancer as the main risk related to MHT, and a high proportion prescribed non-hormonal drugs (86.4%) or alternative therapies (84.5%).Conclusion: Most female gynecologists in this survey would use MHT if menopausal symptoms were present. Postmenopausal physicians use MHT and prescribe it to their symptomatic patients at a higher rate than premenopausal physicians.
Indexation
Artículo de publicación ISI
Quote Item
Climacteric Volumen: 19 Número: 4 Páginas: 387-392 (2016)
Collections